Abstract
Supplementary Figure S1. PCR detects circle junctions for all MYC ecDNA guide pairs tested. Supplementary Figure S2. Hi-C contact frequency, sgRNA indel efficiency, and ecDNA circularization rates in Hap1 and K562 cells. Supplementary Figure S3. ecDNA and scar formation frequencies for initial MYC CRISPR-C guide screen. Supplementary Figure S4. Junction type and microhomology frequency in Hap1, K562, and FTE5 organoids. Supplementary Figure S5. Impact of different MH thresholds on MH frequency across loci and cell types and insertion length distribution at TCGA ecDNA junctions. Supplementary Figure S6. ATR inhibition has no impact on DHFR ecDNA or scar formation efficiency. Supplementary Figure S7. Impact of DNA-PKi and ATMi on ecDNA and scar formation efficiency and MH frequency at various loci. Supplementary Figure S8. Impact of DNA-PKi and ATMi on ecDNA and scar formation efficiency and MH frequency in K562 cells. Supplementary Figure S9. Impact of pharmacologic or genetic manipulation of DDR pathways on the most common circle and scar junction sequences for MYC ecDNA. Supplementary Figure S10. Impact of pharmacologic or genetic manipulation of DDR pathways on the most common circle and scar junction sequences for ecDNA generated from various loci. Supplementary Figure S11. A, Schematic of how the rate of DSB repair can promote or disfavor ecDNA formation. B, Schematic of two models for excisional ecDNA and scar formation.